相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Abstracts of the European Headache and Migraine Trust International Congress 2008 September 4-7, 2008
[Anonymous]
CEPHALALGIA (2009)
Memantine: a comprehensive review of safety and efficacy
Harish Kavirajan
EXPERT OPINION ON DRUG SAFETY (2009)
Anticonvulsants in migraine prophylaxis: a Cochrane review
W. M. Mulleners et al.
CEPHALALGIA (2008)
Memantine in the preventive treatment of refractory migraine
Marcelo Bigal et al.
HEADACHE (2008)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
NMDA receptors in clinical neurology: excitatory times ahead
Lorraine V. Kalia et al.
LANCET NEUROLOGY (2008)
Release of glutamate and CGRP from trigeminal ganglion neurons:: Role of calcium channels and 5-HT1 receptor signaling
Yan Xiao et al.
MOLECULAR PAIN (2008)
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
T. W. Ho et al.
NEUROLOGY (2008)
Formation of NR1/NR2 and NR1/NR3 heterodimers constitutes the initial step in N-methyl-D-aspartate receptor assembly
Thomas Schueler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Memantine for prevention of migraine: a retrospective study of 60 cases
Andrew Charles et al.
JOURNAL OF HEADACHE AND PAIN (2007)
Dose escalating safety study of CNS5161HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain
Thomas Forst et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat:: Therapeutic potential for migraine
Magali Peeters et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Botulinum toxin in headache treatment: the end of the road? Reply
Stefan Evers et al.
CEPHALALGIA (2007)
Recent advances in understanding migraine mechanisms, molecules and therapeutics
Peter J. Goadsby
TRENDS IN MOLECULAR MEDICINE (2007)
Migraine: gene mutations and functional consequences
Arn M. J. M. van den Maagdenberg et al.
CURRENT OPINION IN NEUROLOGY (2007)
The effect of the AMPA/kainate receptor antagonist LY293558 in a rat model of postoperative pain
Hae-Jin Lee et al.
JOURNAL OF PAIN (2006)
Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: A migraine target?
Kevin G. Shields et al.
NEUROBIOLOGY OF DISEASE (2006)
Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo
Brianne Weiss et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Occipital afferent activation of second order neurons in the trigeminocervical complex in rat
K. Le Doare et al.
NEUROSCIENCE LETTERS (2006)
Neurochemistry of trigeminal activation in an animal model of migraine
ML Oshinsky et al.
HEADACHE (2006)
Diverse mechanisms of antiepileptic drugs in the development pipeline
Michael A. Rogawski
EPILEPSY RESEARCH (2006)
Induction of long-lasting changes of visual cortex excitability by five daily sessions of repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers and migraine patients
A Fumal et al.
CEPHALALGIA (2006)
Topiramate inhibits trigeminovascular activation: an intravital microscopy study
S Akerman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures
JC Jen et al.
NEUROLOGY (2005)
Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura
S Akerman et al.
NEUROREPORT (2005)
Ionotropic and metabotropic glutamate receptor structure and pharmacology
JNC Kew et al.
PSYCHOPHARMACOLOGY (2005)
The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke: A double-blind, multicentre, placebo-controlled safety and tolerability study
MR Walters et al.
CEREBROVASCULAR DISEASES (2005)
Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?
KG Shields et al.
BRAIN (2005)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Protective effect of ifenprodil against spreading depression in the mouse entorhinal cortex
LC Faria et al.
JOURNAL OF NEUROPHYSIOLOGY (2004)
Administration of MK-801 decreases c-Fos expression in the trigeminal sensory nuclear complex but increases it in the midbrain during experimental movement of rat molars
Y Hattori et al.
BRAIN RESEARCH (2004)
Cerebrospinal fluid glutamate levels in chronic migraine
MFP Peres et al.
CEPHALALGIA (2004)
Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat
RJ Storer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine
CN Sang et al.
CEPHALALGIA (2004)
Lost productive time and cost due to common pain conditions in the US workforce
WF Stewart et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Significant linkage to migraine with aura on chromosome 11q24
ZM Cader et al.
HUMAN MOLECULAR GENETICS (2003)
Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater
T Bartsch et al.
BRAIN (2003)
Kainate receptors and synaptic transmission
JE Huettner
PROGRESS IN NEUROBIOLOGY (2003)
Migraine can be induced by sildenafil without changes in middle cerebral artery diameter
C Kruuse et al.
BRAIN (2003)
Glutamate receptor functions in sensory relay in the thalamus
TE Salt
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2002)
AMPA antagonist ZK200775 in patients with acute ischemic stroke - Possible glial cell toxicity detected by monitoring of S-100B serum levels
JW Elting et al.
STROKE (2002)
Spreading depression: Imaging and blockade in the rat neocortical brain slice
TR Anderson et al.
JOURNAL OF NEUROPHYSIOLOGY (2002)
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycarbonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester:: A prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine
SA Filla et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Closure of the Venus flytrap module of mGlu8 receptor and the activation process:: Insights from mutations converting antagonists into agonists
AS Bessis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Common and selective molecular determinants involved in metabotopic glutamate receptor agonist activity
HO Bertrand et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Drug therapy: Migraine - Current understanding and treatment.
PJ Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Extracellular glutamate, aspartate and arginine increase in the ventral posterolateral thalamic nucleus during nociceptive stimulation
E Silva et al.
BRAIN RESEARCH (2001)
The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat
JD Classey et al.
BRAIN RESEARCH (2001)
Spreading depression in human neocortical slices
A Gorji et al.
BRAIN RESEARCH (2001)
Prevalence and burden of migraine in the United States: Data from the American Migraine Study II
RB Lipton et al.
HEADACHE (2001)
Co-localization of 5-HT1B/1B/1F receptors and glutamate in trigeminal ganglia in rats
QP Ma
NEUROREPORT (2001)
Brainstem activation specific to migraine headache
A Bahra et al.
LANCET (2001)
Deconstructing migraine headache into peripheral and central sensitization
R Burstein
PAIN (2001)
Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: Differential location relative to pre- and postsynaptic sites
Y Tamaru et al.
NEUROSCIENCE (2001)
Glutamate receptors and nociception - Implications for the drug treatment of pain
ME Fundytus
CNS DRUGS (2001)
Triptans in migraine - A comparative review of pharmacology, pharmacokinetics and efficacy
P Tfelt-Hansen et al.
DRUGS (2000)
Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow
PJ Goadsby et al.
BRAIN RESEARCH (2000)
Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine
H Kaube et al.
NEUROLOGY (2000)
D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor
JP Mothet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The global burden of disease study - Implications for neurology
M Menken et al.
ARCHIVES OF NEUROLOGY (2000)
Contributions of mGlu1 and mGlu5 receptors to interactions with N-methyl-D-aspartate receptor-mediated responses and nociceptive sensory responses of rat thalamic neurons
TE Salt et al.
NEUROSCIENCE (2000)
分享论文
